Journal
PHARMACOLOGICAL RESEARCH
Volume 110, Issue -, Pages 1-9Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2016.05.006
Keywords
Exosome; Ferritin; Apoferritin; Cancer therapy; Drug delivery; Nanotechnology
Categories
Funding
- Marie Curie Actions (CIG) [322158]
- Spanish Ministry of Economy and Competitivity (MINECO) [MAT2012-38161]
- Basque Government [PI2013-56]
Ask authors/readers for more resources
Exosomes and ferritin: Two biomacromolecules from our human bodies both draw increasing interest for advanced drug delivery due to their endogenous origin and their morphology, the cage-like structures. They possess perfect naturally designed structures for loading and shielding of cargo. Their intrinsic biological functions enable a natural delivery of the load and specific targeting. More and more evidences point towards the evolution of a new era of drug delivery strategies with exosomes and ferritin, even for potential personalized therapy. This review focuses on the advantages as well as limits of exosomes and ferritin as endogenous carriers for cancer therapy. We compare their structure-specific cargo loading and their intrinsic cancer-related biological functions. Remaining challenges and promising perspectives for future development to use these two endogenous agents are discussed. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available